Search results
Results from the WOW.Com Content Network
The four journals cover developments across the breadth of therapeutic areas and technologies relevant to the drug discovery and development pipeline. However, as of 2022, these titles have been discontinued and incorporated back into Drug Discovery Today. According to the Journal Citation Reports, the journal has a 2022 impact factor of 8.2. [1]
It was established in 2002 [1] and covers drug discovery and development. The editor-in-chief is Peter Kirkpatrick. [ 2 ] According to the Journal Citation Reports , the journal has a 2021 impact factor of 112.288, ranking it 1st out of 158 journals in the category "Biotechnology & Applied Microbiology" [ 3 ] and 1st out of 279 journals in the ...
The impact factor relates to a specific time period; it is possible to calculate it for any desired period. For example, the JCR also includes a five-year impact factor, which is calculated by dividing the number of citations to the journal in a given year by the number of articles published in that journal in the previous five years. [14] [15]
npj series. The Nature Partner Journals series, abbreviated npj, is a series of online-only, open access, journals.It was launched in April 2014 with three journals: npj Primary Care Respiratory Medicine, npj Biofilms and Microbiomes, and npj Schizophrenia.
SLAS Discovery (Advancing the Science of Drug Discovery) is a peer-reviewed scientific journal published by the Society for Laboratory Automation and Screening (SLAS) in partnership with SAGE Publications. The editor-in-chief is Robert M. Campbell, Ph.D. (Eli Lilly and Company). The journal explores how scientists develop and utilize novel ...
Impact factor. 7.050 (2021) ... Journal homepage; Expert Opinion on Drug Discovery is a monthly peer-reviewed medical journal publishing review articles on novel ...
Pharmaceutical Research is an official journal of the American Association of Pharmaceutical Scientists and covers research spanning the entire spectrum of drug discovery, development, evaluation, and regulatory approval.
Drugs is a peer-reviewed medical journal published by Adis International (Springer Nature) that covers topics in drugs and therapeutics. Besides research articles, the journal also publishes "Adis Drug Evaluations and AdisInsight Reports", evidence-based, single-agent reviews.